Icosagen Revenue
Biotechnology Research • 
Tartu linn, Tartu County, Estonia • 101-200 Employees
Icosagen revenue & valuation
| Annual revenue | $7,000,000 |
| Revenue per employee | $47,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $22,400,000 |
| Total funding | No funding |
Key Contacts at Icosagen
Oliver Schub
Senior Director Business Development
Ulrike Scheffler
Senior Director Business Development
Mart Ustav
Ceo
Andres Männik
Chief Technology Officer
Urve Toots
Managing Director
Company overview
| Headquarters | Eerika tee 1, Tartu, Estonia 61713, EE |
| Phone number | +3727377070 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Research, CRO, Diagnostics, Pharma, Biotech, Process Development, Cell Culture, Gmp Manufacturing, Cdmo, Bispecific Antibodies, Mammalian Cells, Biopharmaceutical Manufacturing, Cell Line Development, Antibody Discovery, Transient Expression, Transmembrane Proteins, Protein Drug Substance Development |
| Founded | 1999 |
| Employees | 101-200 |
| Socials |
Icosagen Email Formats
Icosagen uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@icosagen.com), used 35.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@icosagen.com | 70.1% |
{first initial}.{last name} | j.doe@icosagen.com | 28% |
About Icosagen
Icosagen is a unique European CRDMO, being successfully in the business for more than 25 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates. As a CRDMO we discover, develop, and manufacture proteins seamlessly from research concepts into pre-clinical and clinical development stages. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern 200/1000L GMP facility. In 2024, we continued our partnership with over 100 biotech & pharma companies on 500 projects, producing more than 2000 different proteins.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Icosagen has 53 employees across 9 departments.
Departments
Number of employees
Funding Data
Icosagen has never raised funding before.
Icosagen Tech Stack
Discover the technologies and tools that power Icosagen's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Saudi Arabia
Spain
France
United States
Taiwan, Province of China
ChinaFrequently asked questions
4.8
40,000 users
